[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100600955":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":12,"centralContacts":16,"locations":26,"responsibleParty":79,"collaborators":10,"id":82,"slug":83,"hasResults":84,"nctId":85,"briefTitle":86,"officialTitle":87,"acronym":10,"eligibilityCriteria":88,"healthyVolunteers":84,"sex":89,"minAge":90,"maxAge":10,"enrollmentInfo":91,"targetDuration":94,"studyType":95,"phases":10,"briefSummary":96,"conditions":97,"keywords":101,"overallStatus":29,"whyStopped":10,"lastUpdateSubmitDate":105,"lastUpdatePostDateStruct":106,"startDateStruct":109,"completionDateStruct":111,"leadSponsor":113,"locationsCount":114},{"fullName":5,"class":6},"Zhejiang University","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":10},"Model Development Cohort, External Validation Cohort",null,"Model Development Cohort Definition: 3,000 patients used to identify risk factors and build the prediction mode.\n\nExternal Validation Cohort Definition: 2,000 independent patients from multiple centers to test the model's accuracy.",[13],{"name":14,"affiliation":5,"role":15},"Diansan Su, Dr","STUDY_CHAIR",[17,22],{"name":18,"role":19,"phone":20,"phoneExt":10,"email":21},"Diansan Su, Chief Physician","CONTACT","+8618616514088","diansansu@yahoo.com",{"name":23,"role":19,"phone":24,"phoneExt":10,"email":25},"Mingxia Xu","+8613516713435","xumingxia@zju.edu.cn",[27,50,64],{"facility":28,"status":29,"city":30,"state":31,"zip":32,"country":33,"countryCode":34,"cosmosGeoPoint":35,"geoPoint":40,"contacts":41},"The First Affiliated Hospital, Zhejiang University School of Medicine","RECRUITING","Hangzhou","Zhejiang","310000","China","CN",{"type":36,"coordinates":37},"Point",[38,39],120.16142,30.29365,{"lat":39,"lon":38},[42,43,46,48],{"name":14,"role":19,"phone":20,"phoneExt":10,"email":21},{"name":44,"role":19,"phone":45,"phoneExt":10,"email":10},"Mingxia Su, Dr","＋8613516713435",{"name":14,"role":47,"phone":10,"phoneExt":10,"email":10},"PRINCIPAL_INVESTIGATOR",{"name":23,"role":49,"phone":10,"phoneExt":10,"email":10},"SUB_INVESTIGATOR",{"facility":51,"status":29,"city":52,"state":31,"zip":53,"country":33,"countryCode":34,"cosmosGeoPoint":54,"geoPoint":58,"contacts":59},"The Second Affiliated Hospital of Jiaxing University","Jiaxing","314000",{"type":36,"coordinates":55},[56,57],120.75,30.7522,{"lat":57,"lon":56},[60],{"name":61,"role":19,"phone":62,"phoneExt":10,"email":63},"Hongyuan Sui","+86 13050359876","sui_hongyuan@163.com",{"facility":65,"status":66,"city":67,"state":31,"zip":68,"country":33,"countryCode":34,"cosmosGeoPoint":69,"geoPoint":73,"contacts":74},"The Fifth Affiliated Hospital of Wenzhou Medical University","NOT_YET_RECRUITING","Lishui","323000",{"type":36,"coordinates":70},[71,72],119.91029,28.46042,{"lat":72,"lon":71},[75],{"name":76,"role":19,"phone":77,"phoneExt":10,"email":78},"Zhilan Dou","18857809608","1024734445@qq.com",{"type":47,"investigatorFullName":80,"investigatorTitle":81,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"Diansan Su","Chief Physician,Researcher","100600955","development-and-validation-of-a-risk-prediction-model-for-gastric-retention-in-patients-undergoing-sedated-gastroscopy-100600955",false,"NCT07104214","Development and Validation of a Risk Prediction Model for Gastric Retention in Patients Undergoing Sedated Gastroscopy","Development and Validation of a Risk Prediction Model for Gastric Retention in Patients Undergoing Sedated Gastroscopy: a Multicentre Prospective Cohort Study","Inclusion Criteria:\n\n* Age ≥18 years.\n* Patients scheduled for elective sedated gastroscopy or sedated gastro-colonoscopy.\n* Participant provides informed consent.\n\nExclusion Criteria:\n\n* Acute upper gastrointestinal bleeding (active hematemesis, melena, or confirmed UGIB within 24h).\n* Emergency endoscopic procedures\n* Known pregnancy or lactation\n* Subjects deemed ineligible by investigators","ALL","18 Years",{"count":92,"type":93},5000,"ESTIMATED","1 Day","OBSERVATIONAL","Gastric retention not only compromises the quality of endoscopic examination but also significantly increases the risk of reflux and aspiration in sedated patients. Aspiration of gastric contents represents a critical anesthesia-related complication during the perioperative period, carrying substantial implications for anesthetic management. With the growing volume of sedated gastroscopy procedures, predicting gastric retention has become an urgent clinical priority. This prospective study aims to establish a standardized gastric residual volume (GRV) grading system to evaluate both the volume of retained gastric contents and its contributing factors in patients undergoing upper gastrointestinal endoscopy. We will systematically assess the impact of demographic characteristics, comorbidities, and medication history on gastric emptying function. This study will facilitate establishment of an endoscopy-based simplified assessment system for gastric retention.",[98,99,100],"Gastric Cancer Stage","Esophageal Cancer","Gastroparesis",[102,103,100,104],"Gastric retention","Impaired gastric motility","Delayed gastric emptying","2026-03-09",{"date":107,"type":108},"2026-03-11","ACTUAL",{"date":110,"type":108},"2025-08-03",{"date":112,"type":93},"2026-05-31",{"name":5,"class":6},3]